OTCMKTS:MCVEF Medicover AB (publ) (MCVEF) Stock Price, News & Analysis $15.05 0.00 (0.00%) As of 01/10/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort Interest About Medicover AB (publ) Stock (OTCMKTS:MCVEF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medicover AB (publ) alerts:Sign Up Key Stats Today's Range$15.05▼$15.0550-Day Range$15.05▼$16.4952-Week Range$15.05▼$15.05VolumeN/AAverage Volume3,275 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.Read More… Receive MCVEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicover AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address MCVEF Stock News Headlines3 Growth Companies With High Insider Ownership Expecting Up To 86% Earnings GrowthDecember 12, 2024 | sg.finance.yahoo.comMedicover to evaluate a potential separate listing in IndiaDecember 11, 2024 | finance.yahoo.comTrump plans $32 billion+ AI “Manhattan Project”Our research indicates ONE AI stock is poised to benefit the most. And even OpenAI founder Sam Altman admits the future of AI "depends" on this firm's work. It's currently trading for only $20.January 12, 2025 | Behind the Markets (Ad)MCVEF Medicover AB (publ)November 28, 2024 | seekingalpha.comKlarna Bank AB (publ): Klarna and Worldpay expand partnership to unlock global merchant networkNovember 1, 2024 | finanznachrichten.deMedicover Registered B earnings preview: what Wall Street is expectingJuly 26, 2024 | markets.businessinsider.comCalliditas Therapeutics Ab (publ) (NASDAQ: CALT)February 23, 2024 | fool.comMedicover AB Class B MCOVBsJanuary 17, 2024 | morningstar.comSee More Headlines MCVEF Stock Analysis - Frequently Asked Questions How have MCVEF shares performed this year? Medicover AB (publ)'s stock was trading at $15.05 at the start of the year. Since then, MCVEF shares have increased by 0.0% and is now trading at $15.05. View the best growth stocks for 2025 here. How do I buy shares of Medicover AB (publ)? Shares of MCVEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:MCVEF CUSIPN/A CIKN/A Webwww.medicover.com Phone46.8.400.17.600FaxN/AEmployees45,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:MCVEF) was last updated on 1/12/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredKamala’s final humiliation These ten investments legendary financial analyst Porter Stansberry is exposing after he spent time at Mar-a-L...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicover AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicover AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.